| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 380.38 | 8.2% | 19.5% |
| Total Income | 384.57 | 8.0% | 20.0% |
| Expenditure | 345.34 | 10.2% | 26.2% |
| PBT | 39.23 | 8.1% | 16.2% |
| Net Profit | 29.67 | 4.3% | 15.2% |
| OPM | 13.63% | 1.19pp | 1.23pp |
| NPM | 7.72% | 0.99pp | 3.20pp |
| EPS | 5.18 | 4.4% | 15.4% |
Innova Captab Ltd Reports 19.5% YoY Revenue Growth in Q2 FY26, Strengthens Manufacturing Capabilities
07 Nov 2025 · 7 Nov 2025, 07:26 pm
Summary
Innova Captab Ltd, a leading pharmaceutical company, reported strong results for Q2 FY26 with Revenue from Operations at X 380 crores and EBIDTA at X 56 crores. The company registered a YoY Revenue growth of 19.5% and EBIDTA growth of 8%. The company's manufacturing capabilities were strengthened with successful inspections of its plants in Baddi and Jammu by the UK-MHRA and SMDC respectively.
Key Highlights
- 1
Revenue from Operations registered stellar growth of 19.5% to X 380.4 crores vs X 318.2 crores
- 2
Achieved EBITDA of X 56.1 crores vs X 51.9 crores in Q2 FY25. EBITDA margin for the quarter was 14.7%
- 3
PAT for the quarter stood at X 29.7 crores. PAT margin was 7.8%
- 4
Revenues for H1 FY26 totalled to X 731.9 crores vs X 612.5 crores in H1 FY25
- 5
Registered EBITDA of X 112.6 crores vs X 96.2 crores in H1 FY25. EBITDA margin was 15.4%
- 6
Profit after tax was X 60.7 crores. PAT margin was 8.3%
- 7
Manufacturing capabilities strengthened with successful inspections by UK-MHRA and SMDC
Management Comments
Mr. Vinay Lohariwala
Our strategic initiatives continue to deliver measurable outcomes, as evidenced by YoY revenue growth of 19.5% both in Q2 and H1 FY26 reaching X 380 crores and X 732 crores respectively. We witnessed healthy volume growth, underscoring the sustained demand momentum and operational efficiency achieved through our scale-up efforts. With multiple growth levers in motion — including substantial room for scale-up, geographic diversification, and a robust product pipeline — we are well-positioned to sustain our growth trajectory and deliver a resilient performance across both our business verticals.
Informational and educational content only. Not investment advice.